12/8
04:05 pm
abcl
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Low
Report
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
12/4
10:20 pm
abcl
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
11/26
04:31 pm
abcl
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
11/18
06:32 am
abcl
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
Low
Report
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
11/10
10:57 am
abcl
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
Low
Report
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
11/10
09:00 am
abcl
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
Medium
Report
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
11/9
05:03 am
abcl
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
Medium
Report
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
11/8
01:18 pm
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
11/8
06:57 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
11/7
08:07 am
abcl
AbCellera Biologics (NASDAQ:ABCL) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $4.00 price target on the stock.
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $4.00 price target on the stock.
11/6
04:16 pm
abcl
AbCellera Biologics GAAP EPS of -$0.19 misses by $0.02, revenue of $8.96M beats by $2.63M [Seeking Alpha]
Low
Report
AbCellera Biologics GAAP EPS of -$0.19 misses by $0.02, revenue of $8.96M beats by $2.63M [Seeking Alpha]
11/6
04:05 pm
abcl
AbCellera Reports Q3 2025 Business Results
Medium
Report
AbCellera Reports Q3 2025 Business Results
10/21
10:55 pm
abcl
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
10/7
04:05 pm
abcl
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
Medium
Report
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
10/6
07:36 am
abcl
AbCellera Biologics: Entering Growth Phase After A Pause [Seeking Alpha]
Low
Report
AbCellera Biologics: Entering Growth Phase After A Pause [Seeking Alpha]
10/4
09:12 am
abcl
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline [Yahoo! Finance]
Medium
Report
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline [Yahoo! Finance]
10/3
02:36 pm
abcl
AbCellera Biologics (NASDAQ:ABCL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AbCellera Biologics (NASDAQ:ABCL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/29
04:05 pm
abcl
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
Medium
Report
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
9/29
02:05 pm
abcl
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
9/21
09:35 am
abcl
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond [Yahoo! Finance]
Medium
Report
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond [Yahoo! Finance]
9/20
03:08 am
abcl
AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer [Yahoo! Finance]
9/15
08:31 am
abcl
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 [Yahoo! Finance]
Low
Report
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 [Yahoo! Finance]